文献速递胸部CT

抗合成酶综合征患者序贯高分辨率CT间质性肺病进展的预后因素

Prognostic factors of interstitial lung disease progression at sequential HRCT in anti-synthetase syndrome.
PubMed 文献 · Eur Radiol · 2019-03-27

回顾性纳入69例抗合成酶综合征相关间质性肺病(ASS-ILD)患者,按随访HRCT病变范围变化分为消退、稳定和恶化三组。多因素分析显示,就诊时发热、较低CD3+CD4+细胞计数和普通型间质性肺炎(UIP)模式是ASS-ILD不良结局的三个独立危险因素。

要点

  • 随访HRCT上ILD病变范围变化可分为消退、稳定和恶化三组。
  • 就诊时发热、CD3+CD4+细胞计数低和UIP模式是ASS-ILD不良结局的独立危险因素。
  • 即使接受常规治疗,部分临床特征和HRCT模式仍可能提示肺部受累预后不佳。

核心结论

  • 在ASS起病时,某些临床特征和ILD的HRCT模式可能提示即使接受常规治疗,肺部受累在HRCT上仍呈不良结局,这些因素可能 contribute 于ASS的高长期死亡率。

研究设计与样本

  • 回顾性队列研究,纳入69例间质性肺病且至少一种抗合成酶抗体(抗Jo-1、抗PL7、抗PL12、抗EJ)阳性的患者,记录相关临床特征,根据随访HRCT异常范围变化分为消退组、稳定组和恶化组,采用单因素分析和多因素logistic回归分析预后因素。

关键影像表现/征象

  • 根据随访HRCT异常范围变化将患者分为消退、稳定和恶化三组。
  • 性别、诊断时年龄、就诊时发热和CD3+CD4+细胞计数在三组间差异有统计学意义。
  • 多因素分析显示就诊时发热、较低CD3+CD4+细胞计数和UIP模式是ASS-ILD不良结局的三个独立危险因素。

临床应用与阅片要点

  • 在ASS-ILD患者随访中评估HRCT肺部受累情况很重要。
  • ASS相关间质性肺病对治疗的反应存在差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Interstitial lung disease (ILD) is a common extra-muscular manifestation of anti-synthetase syndrome (ASS) and the main cause of morbidity and mortality in patients with ASS. Data on prognostic factors in these patients are lacking.

METHODS: A total of 69 patients with ILD and positivity for at least one of the following autoantibodies were included: anti-Jo-1, anti-PL7, anti-PL12, and anti-EJ. Relevant clinical characteristics were registered. According to the changes in the extent of abnormalities at the follow-up on high-resolution computed tomography (HRCT), three groups were defined: the regression, stability, and deterioration groups. Univariate analysis was performed to evaluate possible prognostic factors and multivariate analysis by logistic regression was then applied to determine the independent prognostic factors in ASS-ILD.

RESULTS: The cohort comprised 69 patients positive for anti-synthetase antibodies, i.e., 30 for anti-Jo-1, 16 for anti-EJ, 13 for anti-PL7, and 10 for anti-PL12. The mean length of follow-up was 15 months. Sex, age at diagnosis, fever at presentation, and counts of CD3+CD4+ cells were significantly different among the three groups. According to the multivariate analysis, fever at presentation, lower counts of CD3+CD4+ cells, and a pattern of usual interstitial pneumonia were the three independent risk factors for poor outcomes of ASS-ILD.

CONCLUSIONS: At the onset of ASS, some clinical features and HRCT pattern of ILD may suggest an unfavorable outcome of lung involvement on HRCT, even with routine therapy. These factors may contribute to the high long-term mortality of ASS.

KEY POINTS: • Evaluation of lung involvement on HRCT is important in the follow-up of patients with interstitial lung disease related to anti-synthetase syndrome (ASS-ILD). • The interstitial lung disease related to ASS responds to the treatment variably. • Some clinical and imaging characteristics are associated with poor prognosis in patients with ASS-ILD, including fever at diagnosis, a lower serum CD3 + /CD4 + level, and a UIP pattern.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Liu H, Xie S, Liang T, et al. Prognostic factors of interstitial lung disease progression at sequential HRCT in anti-synthetase syndrome. Eur Radiol. 2019. PMID: 30919069. doi:10.1007/s00330-019-06152-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。